Search

everythinglearnresearchcommunity

for

Search:↓

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

New understanding and treatments for hair loss are improving, but more research is needed.

The conclusion is that examining the scalp closely and checking for iron levels and thyroid issues is key to understanding chronic hair loss in women.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

Vitamin C and E may help with certain skin and hair conditions, but more research is needed to confirm their effectiveness.

Scalp skin conditions are more common in young adults and teenagers, especially males, with itching being the main complaint. The most common conditions are psoriasis and alopecia areata, and these can significantly affect a person's social life due to their psychological impact.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Ayurvedic treatment significantly reduced hair loss and improved hair quality in a 30-year-old male.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

A man had a rare skin cancer that looked like a bald spot.

Hair loss in people with darker skin has unique challenges and requires careful diagnosis and treatment.

Certain skin symptoms can help detect and manage systemic lupus.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

The document describes skin diseases affecting the outer ear in dogs and cats, their spread to other body parts, and treatment options.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Ashy dermatosis may be linked to atopy and thyroid disease and can be treated with topical steroids.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

A woman with lupus had rare severe symptoms but improved with treatment.

No single biomarker is reliable enough for diagnosing and assessing SLE.